Evidence map›Paper›PMID 22605974›Full record

ReviewInternational journal of molecular sciences2012

Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health.

Ali Mobasheri, Yves Henrotin, Hans-Konrad Biesalski, Mehdi Shakibaei

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05896878 (The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients), which is not on this map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05896878 naterminatednot on this mapstarted 2023, after this paper: background citation

The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients

TypeinterventionalSponsorHudson MedicalRan2023 to 2024Enrolled1ConditionsPain, Chronic, Opioid Dependence, Opioid Use, Inflammation ChronicArmsRoot.Health Dietary Supplement
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Efficacy ofJournal of rheumatic diseases · 2025
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Potential of Natural Products as Therapeutic Agents for Inflammatory Diseases.Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2024
    Review
  14. Article
  15. Therapeutic effects of combining curcumin and swimming in osteoarthritis using a rat model.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
    Article
  16. Curcumin ameliorates HExperimental and therapeutic medicine · 2022
    Article
  17. Review
  18. Ingredients of a Natural Oral Nutritional Supplement and Their Role in the Treatment of Osteoarthritis.Clinical medicine insights. Arthritis and musculoskeletal disorders · 2022
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Ali MobasheriMusculoskeletal Research Group, School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, The University of Nottingham, Sutton Bonington, LE12 5RD, UK.
Yves HenrotinBone and Cartilage Research Unit, Institute of Pathology, University of Liège, Sart-Tilman, 4000 Liège, Belgium.
Hans-Konrad BiesalskiDepartment of Biological Chemistry and Nutrition, University of Hohenheim, D-70593 Stuttgart, Germany.
Mehdi ShakibaeiMusculoskeletal Research Group, Institute of Anatomy, Ludwig-Maximilian-University Munich, Pettenkoferstrasse 11, D-80336 Munich, Germany.
Ludwig-Maximilians-Universität München · DEUniversity of Hohenheim · DEUniversity of Liège · BEUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) are key cytokines that drive the production of inflammatory mediators and matrix-degrading enzymes in osteoarthritis (OA). These proinflammatory cytokines bind to their respective cell surface receptors and activate inflammatory signaling pathways culminating with the activation of nuclear factor κB (NF-κB), a transcription factor that can be triggered by a host of stress-related stimuli including, excessive mechanical stress and ECM degradation products. Once activated, NF-κB regulates the expression of many cytokines, chemokines, adhesion molecules, inflammatory mediators, and several matrix-degrading enzymes. Therefore, proinflammatory cytokines, their cell surface receptors, NF-κB and downstream signaling pathways are therapeutic targets in OA. This paper critically reviews the recent literature and outlines the potential prophylactic properties of plant-derived phytochemicals such as curcumin and resveratrol for targeting NF-κB signaling and inflammation in OA to determine whether these phytochemicals can be used as functional foods.

Indexed as

Angiogenesis InhibitorsAnti-Inflammatory Agents, Non-SteroidalArthritis, RheumatoidCartilage, ArticularChondrocytesCurcuminHumansInflammationInterleukin-1betaJointsOsteoarthritisPhytochemicalsPhytotherapyResveratrolStilbenesTranscription Factor RelAAngiogenesis InhibitorsAnti-Inflammatory Agents, Non-SteroidalCurcuminIL1B protein, humanInterleukin-1betaPhytochemicalsRELA protein, humanResveratrolStilbenesTranscription Factor RelATumor Necrosis Factor-alphaarticular cartilagecurcuminfunctional foodOAosteoarthritisphytochemicalRAresveratrolrheumatoid arthritis

Identifiers

PMID22605974
PMCPMC3344210
OpenAlexW2167597391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.